Please login to the form below

Not currently logged in
Email:
Password:

Mitsubishi Tanabe Pharma

This page shows the latest Mitsubishi Tanabe Pharma news and features for those working in and with pharma, biotech and healthcare.

GSK files anaemia drug daprodustat in Japan, its first market

GSK files anaemia drug daprodustat in Japan, its first market

class called vadadustat in late-stage clinical testing that is licensed to Mitsubishi Tanabe Pharma in some Asian markets including Japan. ... Astellas Pharma meanwhile has rights to roxadustat in Japan and Europe and has phase 3 trials on the go in

Latest news

  • Voice biomarker device could diagnose depression, heart disease Voice biomarker device could diagnose depression, heart disease

    The financing round was led by M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, Germany), with MP Healthcare Venture Management (the corporate venture capital arm of Mitsubishi Tanabe ... Pharma), Neoteny 4, LP, Canepa Healthcare,

  • Biogen picks up another drug from wide-ranging Ionis alliance Biogen picks up another drug from wide-ranging Ionis alliance

    It was joined last year by Mitsubishi Tanabe Pharma’s Radicava/Radicut (edaravone) last year, which provides another options, but there is still a desperate need for additional therapies. ... Pharma’s ODM-109 (oral levosimendan) which was advanced to

  • Mitsubishi buys Israel's NeuroDerm for $1.1bn Mitsubishi buys Israel's NeuroDerm for $1.1bn

    Japan's Mitsubishi Tanabe Pharma has boosted its pipeline with a $1.1bn deal to buy NeuroDerm, an Israeli developer of central nervous system therapies. ... Adding ND0612 into the portfolio will help Mitsubishi meet its target of driving US sales to 80bn

  • FDA clears new ALS drug Radicava ahead of schedule FDA clears new ALS drug Radicava ahead of schedule

    MT Pharma’s medicine will soon offer US patients an alternative to Sanofi’s Rilutek. ... Patients with the chronic neurodegenerative disease amyotrophic lateral sclerosis (ALS) have a new treatment option in the US after the FDA approved Mitsubishi

  • GSK starts late-stage trials of daprodustat GSK starts late-stage trials of daprodustat

    Also in phase III is Akebia Pharma's vadadustat, which has been licensed to Mitsubishi Tanabe Pharma in some Asian markets including Japan. .

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    4. Vadadustat is an inhibitor of hypoxiainducible factor (HIF)-prolyl hydroxylase (HIF-PH) from Akebia Therapeutics/ Mitsubishi Tanabe Pharma/Otsuka that targets anaemia in chronic kidney disease (CKD).

  • Deal Watch September 2016 Deal Watch September 2016

    India's Sun Pharmaceutical has partnered with Mitsubishi Tanabe Pharma to distribute and market 14 prescription drugs in Japan that Sun recently acquired from Novartis. ... Upfront $80m plus $830m in milestones [ex S. Korea]. 910. Raptor / Horizon Pharma.

  • Deal Watch October 2015 Deal Watch October 2015

    This was exemplified by the major asset swapping amongst pharma companies of last year. ... Collaboration, option to license. 339. Regeneron Pharmaceuticals/ Mitsubishi Tanabe Pharma. Fasinumab (REGN475), nerve growth factor  mAb for musculoskeletal

  • Pharma deals during December 2014 Pharma deals during December 2014

    OTX015 was originally in-licensed from Mitsubishi Tanabe Pharma Corporation in March 2012 following completion of phase I studies in healthy volunteers. ... See a table listing all the major pharma mergers, acquisitions and collaborations agreed during

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    For an indepth analysis of these deals, read'Pharma deals during July 2013'. ... 210. Medicago / Mitsubishi Tanabe Pharma. Acquisition of 60% stake. Portfolio of flu and other vaccines based on VLPs (p2).

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...

Infographics